56441-69-1

Usage

Uses

Used in Pharmaceutical Research and Development:
4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER is used as a key building block in the synthesis of new pharmaceutical compounds, contributing to the advancement of medical treatments.
Used in Organic Synthesis:
In the field of organic synthesis, 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER is utilized as a crucial component for creating complex organic molecules, facilitating the development of novel chemical entities.
Used in Medicine:
4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER is used as a modifier to enhance the properties of certain drugs, potentially improving their efficacy, safety, or other pharmacological characteristics.
Used in Pain-Relief Medications:
Due to its anti-inflammatory and analgesic effects, 4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER is used as an active ingredient in the development of medications aimed at providing relief from pain and reducing inflammation.
Used in Anti-Inflammatory Treatments:
4-BENZYLOXYPHENYLACETIC ACID ETHYL ESTER's anti-inflammatory properties make it suitable for use in treatments targeting conditions characterized by inflammation, where it can help manage symptoms and promote healing.

InChI:InChI=1/C17H18O3/c1-2-19-17(18)12-14-8-10-16(11-9-14)20-13-15-6-4-3-5-7-15/h3-11H,2,12-13H2,1H3

Upstream product

• 17138-28-2 (4-hydroxy-phenyl)-acetic acid ethyl ester 
• 100-39-0 benzyl bromide 
• 4397-53-9 p-benzyloxybenzaldehyde 
• 100-44-7 benzyl chloride 
• 64-17-5 ethanol 
• 71749-20-7 1-Benzyloxy-4-((Z)-2-methanesulfinyl-2-methylsulfanyl-vinyl)-benzene 

Downstream Products

• 5884-31-1 2-(4-benzyloxyphenyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide 
• 1126-93-8 2-ethoxy-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 1454797-91-1 ethyl 2,3,3-tris(4-(benzyloxy)phenyl)propionate 
• 1258603-05-2 trans-5-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-04-1 cis-5-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-03-0 trans-5-(4-((5-methyl-6-((1-(pyrimidin-2-yl)piperidin-4-yl)oxy)pyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258603-02-9 cis-5-(4-((5-methyl-6-((1-(pyrimidin-2-yl)piperidin-4-yl)oxy)pyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258602-99-1 trans-5-(4-((6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 1258602-98-0 cis-5-(4-((6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-nitropyrimidin-4-yl)oxy)phenyl)-1,3,2-dioxathiane 2-oxide 
• 155062-29-6 2-[4-(benzyloxy)phenyl]-1,3-propanediol 
• 1258604-43-1 2-(4-((2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazol-4-yl)methoxy)phenyl)propane-1,3-diol 
• 1258604-42-0 4-((4-(2,2-dimethyl-1,3-dioxan-5-yl)phenoxy)methyl)-2-(1-(pyrimidin-2-yl)piperidin-4-yl)thiazole 

Relevant academic research and scientific papers

Boron-Catalyzed Azide Insertion of α-Aryl α-Diazoesters

A challenging metal-free azide insertion of α-aryl α-diazoesters in the presence of B(C6F5)3 (5 mol %) was developed for the first time. The reaction features an easy operation, wide substrate scope, and mild conditions an

IMIDAZO(1,2-a)PYRIDINE DERIVATIVE

A compound reprsented by the following formula (I), its salts or nsolvates thereof capable of specifically or selectively expressig an antifungal activity in a broad spectrum based on the novel mechanism thereof of 1,6-β-glucan synthesis inhibition, and an antifungal agent containing any of them.

1,2-disubstituted-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof

The invention relates to combinatorial libraries containing two or more novel piperidine-3-carboxamide derivative compounds, methods of preparing the piperidine-3-carboxamide derivative compounds and piperidine-3-carboxamide derivative compounds bound to a resin

Total synthesis of (2S,3s,4R)-plakoridine A

The β-amino ester 6 is synthesized via the diastereoselective Michael addition of the lithium amide derived from amine 5 to methyl (E)-2-hexenoate. This ester is converted to the pyrrolidinone 8 via an aldol condensation/deprotection/cyclization. Transformation of the lactam 8 into thiolactam 11 followed by Eschenmoser sulfide contraction provides (2S,3S,4R)-plakoridine A. (C) 2000 Elsevier Science Ltd.

Anti-glaucoma agent

1-{4-[2-(Cyclopropylmethoxy)-ethyl]-phenoxy}-3-isopropylamino-propan-2-ol and its pharmaceutically acceptable salts, in the form of a racemate or optical isomer, are useful as topical anti-glaucoma agents.

PHENOL ETHERS

The invention provides phenol ethers of the formula: STR1 wherein R is branched C 3-4 alkyl, C 3-4 cycloalkyl, branched cyano(C 3-4 alkyl), phenyl(C 2-3 alkyl), halophenyl(C 2-3 alkyl), (C 1-4 alkoxy)phenyl(C 2-4 alkyl), or (C 1-4 acyl) amino(C 1-4 alkyl),alk is C 1-4 alkyl substituted by a 3 to 6 membered cycloalkyl group,X is--O--,--S--or--SO 2--; andR 1 is--C 1-4 alkyl-or--C 1-4 alkoxy-, in their racemic and optically active forms, and their addition salts with pharmaceutically acceptable acids. These compounds are useful in therapy as β-adrenergic blocking agents. Intermediates are also provided.

Hypolipidemic analogues of ethyl 4 benzyloxybenzoate

A series of compounds related to ethyl 4-benzyloxybenzoate was synthesized and evaluated for potential hypolipidemic activity in rats. Structure-activity relationships are discussed in terms of cholesterol-lowering activity together with effects on body weight gain and liver lipids. A number of the compounds inhibited cholesterol and free fatty acid biosynthesis from [1-14C]acetate in rat liver slices in vitro. Ethyl 4-benzyloxybenzoate, ethyl 4-benzyloxybenzoic acid, ethyl 4-p-bromobenzyloxybenzoate, and ethyl 4-o-methoxybenzyloxyphenyl acetate exhibited the most favorable spectrum of activity.